CagriSema Fails to Meet Expectations in Late-Stage Obesity Trial, but Still Beats PlaceboNovo Nordisk's CagriSema obesity treatment underperformed in trials, showing lower weight loss than anticipated compared to Wegovy.
Everything You Need to Know About Wegovy, the Weight Loss Wonder DrugWegovy, a semaglutide injection, aids in weight loss by suppressing appetite and boosting metabolism, now available in South Korea.
Weight Loss Drug Semaglutide Could Alleviate Knee Osteoarthritis Pain, Study ShowsA study reveals semaglutide may alleviate knee osteoarthritis pain in obese patients, highlighting its potential beyond diabetes treatment.
Must-Reads
1
Will Korea-China summit rekindle hopes of K-culture comeback in China?
LATEST
2
Workers may soon be able to ignore late-night work messages
LATEST
3
International matchmakers under scrutiny over consumer harm
LATEST
4
Nearly 25 Islamic State fighters killed or captured in Syria, US military says
LATEST
5
Hanwha Life wins ISO certification for AI security
CagriSema Fails to Meet Expectations in Late-Stage Obesity Trial, but Still Beats Placebo Novo Nordisk's CagriSema obesity treatment underperformed in trials, showing lower weight loss than anticipated compared to Wegovy.
Everything You Need to Know About Wegovy, the Weight Loss Wonder Drug Wegovy, a semaglutide injection, aids in weight loss by suppressing appetite and boosting metabolism, now available in South Korea.
Weight Loss Drug Semaglutide Could Alleviate Knee Osteoarthritis Pain, Study Shows A study reveals semaglutide may alleviate knee osteoarthritis pain in obese patients, highlighting its potential beyond diabetes treatment.
Hot Topics